Dr. Nora Schmidt

My Research Interest in RESIST

My research within RESIST focuses on deciphering the role of RNA-protein interactions in viral disease mechanisms and antiviral defense processes in RSV and HSV-1 infections. We will identify candidate RNA-binding proteins and illuminate their mechanistic function in modulating viral or host RNAs during the viral life cycle and the IFN response. Our methodology includes advanced sequencing techniques, as well as cell-based virological and biochemical assays. By integrating information of genetic variants from the RESIST cohorts, we will contribute to a better understanding of disease processes and susceptibility in patients at risk for severe viral disease.

Dr. Nora Schmidt in the MHH virology laboratory

Dr. Nora Schmidt – Curriculum Vitae

Current Position

  • Junior Group Leader, Institute of Virology, Hannover Medical School (MHH), Germany

Undergraduate and Postgraduate Training

  • 2009 – 2013 BSc, Technical Biology, University of Stuttgart, Germany

  • 2013 – 2015 MSc, Technical Biology, University of Stuttgart, Germany

  • 2014 MSc Project at Imperial College London, UK (Supervisor: Prof. Peter O’Hare)

  • 2015 – 2019 PhD, Institute of Medical Virology, Life Science Zurich Graduate School, University of Zurich, Switzerland (Supervisor: Prof. Benjamin Hale)

Academic and Research Posts

  • 2020 – 2024 Postdoctoral Researcher, Helmholtz Institute for RNA-based Infection Research, Würzburg, Germany (Supervisor: Prof. Mathias Munschauer)

  • Since 06/2024 Junior Group Leader, Institute of Virology, Hannover Medical School (MHH), Germany

Awards and Prizes

  • 2020 EMBO Postdoctoral Fellowship

  • 2024 Robert-Koch Postdoctoral Award in Virology

  • 2024 „For Women in Science“-Award from L’Oréal, the German UNESCO Commission and the German Humboldt Network

Recommended Links

For further information about Dr. Schmidt’s scientific work please check the following link:

10 Selected Publications

Aydin, J., A. Gabel, S. Zielinski, S. Ganskih, N. Schmidt, C. R. Hartigan, M. Schenone, S. A. Carr, and M. Munschauer. 2024. SHIFTR enables the unbiased identification of proteins bound to specific RNA regions in live cells. Nucleic Acids Res 52: e26. PMID: 38281241.

Schmidt, N., S. Ganskih, Y. Wei, A. Gabel, S. Zielinski, H. Keshishian, C. A. Lareau, L. Zimmermann, J. Makroczyova, C. Pearce, K. Krey, T. Hennig, S. Stegmaier, L. Moyon, M. Horlacher, S. Werner, J. Aydin, M. Olguin-Nava, R. Potabattula, A. Kibe, L. Dolken, R. P. Smyth, N. Caliskan, A. Marsico, C. Krempl, J. Bodem, A. Pichlmair, S. A. Carr, P. Chlanda, F. Erhard, and M. Munschauer. 2023. SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. Cell 186: 4834-4850 e4823. PMID: 37794589.

Pekayvaz, K., A. Leunig, R. Kaiser, M. Joppich, S. Brambs, A. Janjic, O. Popp, D. Nixdorf, V. Fumagalli, N. Schmidt, V. Polewka, A. Anjum, V. Knottenberg, L. Eivers, L. E. Wange, C. Gold, M. Kirchner, M. Muenchhoff, J. C. Hellmuth, C. Scherer, R. Rubio-Acero, T. Eser, F. Deak, K. Puchinger, N. Kuhl, A. Linder, K. Saar, L. Tomas, C. Schulz, A. Wieser, W. Enard, I. Kroidl, C. Geldmacher, M. von Bergwelt-Baildon, O. T. Keppler, M. Munschauer, M. Iannacone, R. Zimmer, P. Mertins, N. Hubner, M. Hoelscher, S. Massberg, K. Stark, and L. Nicolai. 2022. Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection. Nat Commun 13: 1018. PMID: 35197461.

Borold, J., D. Eletto, I. Busnadiego, N. K. Mair, E. Moritz, S. Schiefer, N. Schmidt, P. P. Petric, W. W. Wong, M. Schwemmle, and B. G. Hale. 2021. BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity. EMBO Rep 22: e52823. PMID: 34397140.

Schmidt, N., C. A. Lareau, H. Keshishian, S. Ganskih, C. Schneider, T. Hennig, R. Melanson, S. Werner, Y. Wei, M. Zimmer, J. Ade, L. Kirschner, S. Zielinski, L. Dolken, E. S. Lander, N. Caliskan, U. Fischer, J. Vogel, S. A. Carr, J. Bodem, and M. Munschauer. 2021. The SARS-CoV-2 RNA-protein interactome in infected human cells. Nat Microbiol 6: 339-353. PMID: 33349665.

Schmidt, N., P. Domingues, F. Golebiowski, C. Patzina, M. H. Tatham, R. T. Hay, and B. G. Hale. 2019. An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity. Proc Natl Acad Sci U S A 116: 17399-17408. PMID: 31391303.

Sekine, E., N. Schmidt, D. Gaboriau, and P. O’Hare. 2017. Spatiotemporal dynamics of HSV genome nuclear entry and compaction state transitions using bioorthogonal chemistry and super-resolution microscopy. PLoS Pathog 13: e1006721. PMID: 29121649.

Schmidt, N., T. Hennig, R. A. Serwa, M. Marchetti, and P. O’Hare. 2015. Remote Activation of Host Cell DNA Synthesis in Uninfected Cells Signaled by Infected Cells in Advance of Virus Transmission. J Virol 89: 11107-11115. PMID: 26311877.

Shukla, S., F. J. Eber, A. S. Nagarajan, N. A. DiFranco, N. Schmidt, A. M. Wen, S. Eiben, R. M. Twyman, C. Wege, and N. F. Steinmetz. 2015. The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods. Adv Healthc Mater 4: 874-882. PMID: 25641794.

Contact

  Dr. Nora Schmidt
   Institut für Virologie
Medizinische Hochschule Hannover
  Carl-Neuberg-Str. 1
30625 Hannover
  +49 511 532 – 2435
  schmidt.nora@
mh-hannover.de